AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3) - Daniel D Murray, Abdel G Babiker, Jason

Insilico Medicine achieves AI drug discovery breakthrough

Undetectable AI Free tool

AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

TCER® IMA402

D-FW biotech firm completes “first ever” AI clinical trial

TechNode

Sally Ann Frank on LinkedIn: AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

Insilico Medicine achieves AI drug discovery breakthrough

Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes

VinBrain collaborates with Microsoft to expand AI-powered healthcare to patients worldwide - TNGlobal

Beyond Discovery: Leveraging AI To Accelerate Clinical Trials

TCDI Announces Strategic Partnership with Altumatim to Elevate AI-Powered Document Review and Data Intelligence

New Clinical Trial Focuses on Targeted Alpha-Emitter Therapy of PRRT - NETRF